Comparison of the results of intravenous dilatation by balloon before anastomosis with the usual method for the insertion of arteriovenous fistula in chronic renal failure patients

Document Type : Original Article

Authors

1 Assistant Professor of Surgery.Department of Surgery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz,Iran.

2 resident of Surgery.Department of Surgery, Ahvaz Jundishapur University of Medical Sciences, Ahvaz,Iran.

3 Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Abstract

Abstract
Introduction: The main objective of the present study was to evaluate the effect of Primary balloon angioplasty (PBA) versus hydrostatic dilatation (HD)in the fitting of suitable fistulas for hemodialysis .
Methods and Materials:in An interventional study 38 patients were compared.
in two groups of 19patients among patients.

Results: There was no difference in risk factors between the two groups. There was no fistula deficiency in the PBA group and all fistulas were functional in this group. The rate of intervention in PBA relative to HD was significantly increased from 5 to 42%, respectively. The mean age of puberty was 53 days in HD and 31 days in PBA, which was significant.

Conclusion:
PBA is a safe and efficient procedure for embedding necessary fistulas for dialysis, especially in small veins.
This initial duct opening procedure has fewer times and less reciprocal intervention

Key words: dilatation, Primary balloon angioplasty, hydrostatic, hemodialysis

Keywords

References

1-Asadi F,Moghadaasi H,Rabiei R,Malekzadeh S.study on the status of information system for dialysis patients in the country.Hakim health sys Res 2017;20(2):93-98.
2-Dhingra RK, Young EW, Hulbert-Shearon TE, Leavey SF, Port FK.Type of vascular access and mortality in U.S. hemodialysis patients.Kidney. Int 2001;60:1443-51.
3-Young E. Vascular access. Current practice and practical aspects ofmanagement, ASN renal week 2000. Toronto: American Society of Nephrology; 2000, p. 377-85.
4-Murphy GJ, White SA, Nicholson ML. Vascular access for haemodialysis.Br J Surg 2000;87:1300-15.
5-Ascher E, Gade P, Hingorani A, Mazzariol F, Gunduz Y, Fodera M, etal. Changes in the practice of angioaccess surgery: impact of dialysis outcome and quality initiative recommendations. J Vasc Surg 2000;31(1):84-92.
6-Kherlakian GM, Roedersheimer LR, Arbaugh JJ, Newmark KJ, King LR. Comparison of autogenous fistula versus expanded polytetrafluoroethylene graft fistula for angioaccess in hemodialysis. Am J Surg.2016;152:238-43.
7-Oliver MJ, Rothwell DM, Fung K, Hux JE, Lok CE. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol. 2004;15:1936-42.
8-Allon M, Robbin ML. Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2012;62:1109-24.
9-Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Moll FL, Blankestijn PJ, et al. Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative. Clin J Am Soc Nephrol.2008;3:714-9.
10-Grogan J, Castilla M, Lozanski L, Griffin A, Loth F, Bassiouny H.Frequency of critical stenosis in primary arteriovenous fistulae before hemodialysis access: should duplex ultrasound surveillance be the standard of care? J Vasc Surg 2005;41:1000-6.
11-Sidawy AN, Gray R, Besarab A, Henry M, Ascher E, Silva M Jr, et al.Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2012;35:603-10.
12-Janson MK,smeeth N, Young CJ, et al. Arteriovenous Fistula First Breakthrough Coalition. Am J Surg.2014;11:231-7.
13-Allon M, Lockhart ME, Lilly RZ, Gallichio MH, BarkerJ, et al. Effect of preoperative sonographic mapping on vascular access outcomes in hemodialysis patients. Kidney Int 2001;60:2013-20.
14-Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival:Upper arm native arteriovenous fistula. Am J Kidney Dis 2002;39:92-101.
15-Oliver MJ, McCann RL, Indridason OS, Butterly DW, Schwab SJ.Comparison of transposed brachiobasilic fistulas to upper arm grafts andbrachiocephalic fistulas. Kidney Int 2001;60:1532-9.
16-Rocco MV, Bleyer AJ, Burkart JM. Utilization of inpatient and outpatientresources for the management of hemodialysis access complications.Am J Kidney Dis 20066;28:250-6.
17-De Marco Garcia LP, Davila-Santini LR, Feng Q, Calderin J, Krishnasastry KV, Panetta TF. Primary balloon angioplasty plus balloon angioplasty maturation to upgrade small-caliber veins (3 mm) for arteriovenous fistulas. J Vasc Surg 2010;52:139-44.
18-Lipari G, Tessitore N, Poli A, Bedogna V, Impedovo A, Lupo A, et al. Outcomes of surgical revision of stenosed and thrombosed forearm arteriovenous fistulae for haemodialysis. Nephrol Dial Transplant 2007;22:2605-12.
19-Tessitore N, Mansueto G, Bedogna V, Lipari G, Poli A, Gammaro L, et al. A prospective controlled trial on effect of percutaneous transluminal angioplasty on functioning arteriovenous fistulae survival. J Am SocNephrol 2003;14:1623-7.
20-Tessitore N, Lipari G, Poli A, Bedogna V, Baggio E, Loschiavo C, et al. Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study. Nephrol Dial Transplant 2004;19:2325-33.
21-Karakayali F, Basaran O, Ekici Y, Budakoglu I, Aytekin C, Boyvat F, et al. Effect of secondary interventions on patency of vascular access sites for hemodialysis. Eur J Vasc Endovasc Surg 2006;32:701-9.
22-Beathard GA. Percutaneous transvenous angioplasty in the treatment of vascular access stenosis. Kidney Int 1992;42:1390-7.
23-Long B, Brichart N, Lermusiaux P, Turmel-Rodrigues L, Artru B, Boutin JM, et al. Management of perianastomotic stenosis of direct wrist autogenous radial-cephalic arteriovenous accesses for dialysis. J Vasc Surg 2011;53:108-14.
24-Andrassy K, Malluche H, Bornefeld H, Comberg M, Ritz E, Jesdinsky H, et al. Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochensch.2004;52:348-9.
25-Albert F. Prevention of early thrombus formation in arteriovenous fistula. Dial Transplant 2010;10:167-72.
26-Gröntoft KC, Mulec H, Gutierrez A, Olander R. Thromboprophylactic effect of ticlopidine in arteriovenous fistulas for haemodialysis. Scand J Urol Nephrol 1985;19:55-7.
27-Fiskerstrand CE, Thompson IW, Burnet ME, Williams P, Anderton JL. Double-blind randomized trial of the effect of ticlopidine in arteriovenous fistulas for hemodialysis. Artif Organs 2005;9:61-3.
28-Janicki K, Dmoszyn´ ska A, Janicka L, Stettner S, Jesipowicz J. Influence of antiplatelet drugs on occlusion of arteriovenous fistula in uraemic bpatients. Int Urol Nephrol 2012;24:83-9.
29-Janicki K, Janicka L, Dmoszynska A, Marczewski K, Smarz I. Effects of ticlopidine on platelet activity and occlusion of arteriovenous fistulas in IPD patients. Dial Transplant 2004;23:576-9.
30-Gröntoft KC, Larsson R, Mulec H, Weiss LG, Dickinson JP. Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study Group. Scand J Urol Nephrol 2008;32:276-83.
31-Dember LM, Beck GJ, Allon M, Delmez JA, Dixon BS, Greenberg A, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008;299:2164-71.
Jundishapur Scientific Medical Journal
Volume 18, Issue 2 - Serial Number 119
July and August 2019
Pages 171-178

Files

History

  • Receive Date: 19 December 2018
  • Revise Date: 13 July 2019
  • Accept Date: 22 July 2019

Share

How to cite

Statistics